{
    "clinical_study": {
        "@rank": "134607", 
        "acronym": "ALARM-vs-AF", 
        "arm_group": [
            {
                "arm_group_label": "MVS + maze", 
                "arm_group_type": "Active Comparator", 
                "description": "Procedure: Maze procedure, mitral valve surgery\nThe scheme of lesion pattern: \"box\" lesion + line to mitral valve + line from \"box\" to left atrial appendage. The ablation procedure was performed by using a dry bipolar radiofrequency ablation clamp.\nThe left atrial appendage was excluded in all cases. For mitral regurgitation or stenosis, the procedures will be a valve repair in the majority of cases. For valves that are not amenable to repair, a valve replacement will be performed."
            }, 
            {
                "arm_group_label": "MVS + maze + LA reduction", 
                "arm_group_type": "Experimental", 
                "description": "Procedure: maze procedure, mitral valve surgery, left atrial reduction\nThe scheme of lesion pattern: \"box\" lesion + line to mitral valve + line from \"box\" to left atrial appendage. The ablation procedure was performed by using a dry bipolar radiofrequency ablation clamp.\nThe left atrial appendage was excluded in all cases. For mitral regurgitation or stenosis, the procedures will be a valve repair in the majority of cases. For valves that are not amenable to repair, a valve replacement will be performed.\nThe enlarged left atria are plicated (suture technique) between the left and right pulmonary vein down to the inferior end of left atrial incision on the half-moon shape."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to estimate left atrial volume reduction surgery  concomitant\n      with the maze procedure and mitral valve repair/replacement in patients with atrial\n      fibrillation with an enlarged left atria."
        }, 
        "brief_title": "Ablation and Left Atrium Reduction During Mitral Valve Surgery for Atrial Fibrillation", 
        "completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Atrial Fibrillation", 
        "condition_browse": {
            "mesh_term": "Atrial Fibrillation"
        }, 
        "detailed_description": {
            "textblock": "The Cox-Maze procedure has been a gold standard for the treatment of atrial fibrillation.\n      Success of the modified maze procedure after valvular operation with an enlarged left atria\n      and persistent and longstanding persistent atrial fibrillation remains suboptimal. The\n      question addressed was: In adults undergoing a maze procedure for atrial fibrillation does\n      left atrial size reduction compared to maze surgery alone improve maze surgery success?"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Able to sign Informed Consent and Release of Medical Information forms\n\n          -  Age \u2265 18 years\n\n          -  Clinical indications for mitral valve surgery for organic mitral valve disease Note:\n             May include need for surgical management of functional tricuspid regurgitation or\n             patent foramen ovale. Surgical intervention may be performed via sternotomy or\n             minimally invasive procedure.\n\n          -  a) Persistent atrial fibrillation (AF) within 6 months prior to randomization,\n             defined as non self-terminating AF lasting greater than 7 days but no more than one\n             year, or lasting less than 7 days but necessitating pharmacologic or electrical\n             cardioversion.\n\n        Duration of AF must be documented by medical history and Presence of AF must be documented\n        by a direct electrocardiographic assessment within 6 months prior to randomization.\n\n        b) Longstanding persistent AF is defined as continuous AF of greater than one year\n        duration.\n\n        Duration of AF must be documented by medical history and Presence of AF must be documented\n        by a direct electrocardiographic assessment upon arrival in the OR.\n\n          -  left atrial diameter > 65mm\n\n          -  Able to use heart rhythm monitor\n\n        Exclusion Criteria:\n\n          -  AF is paroxysmal\n\n          -  AF without indication for mitral valve surgery\n\n          -  Concomitant coronary artery bypass grafting (CABG), aortic arch or aortic valve\n             procedure\n\n          -  Previous catheter ablation for AF\n\n          -  Redo cardiac surgery\n\n          -  Left ventricle ejection fraction (LV EF) < 35%\n\n          -  Life expectancy of less than one year\n\n          -  Mental impairment or other conditions that may not allow subject to understand the\n             nature, significance, and scope of study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 24, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02047279", 
            "org_study_id": "14-04-31491"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "MVS + maze", 
                    "MVS + maze + LA reduction"
                ], 
                "description": "The scheme of lesion pattern: \"box\" lesion + line to mitral valve + line from \"box\" to left atrial appendage. The ablation procedure was performed by using a dry bipolar radiofrequency ablation clamp. The left atrial appendage was excluded in all cases.", 
                "intervention_name": "maze procedure", 
                "intervention_type": "Procedure", 
                "other_name": [
                    "surgical ablation", 
                    "radiofrequency ablation"
                ]
            }, 
            {
                "arm_group_label": [
                    "MVS + maze", 
                    "MVS + maze + LA reduction"
                ], 
                "description": "For mitral regurgitation or stenosis, the procedures will be a valve repair in the majority of cases. For valves that are not amenable to repair, a valve replacement will be performed.", 
                "intervention_name": "mitral valve surgery", 
                "intervention_type": "Procedure", 
                "other_name": [
                    "mitral valve repair", 
                    "mitral velve replacement"
                ]
            }, 
            {
                "arm_group_label": "MVS + maze + LA reduction", 
                "description": "The enlarged left atria are plicated (suture technique) between the left and right pulmonary vein down to the inferior end of left atrial incision on the half-moon shape.", 
                "intervention_name": "left atrial reduction", 
                "intervention_type": "Procedure", 
                "other_name": "left atrial volume reduction"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Atrial fibrillation", 
            "Mitral valve"
        ], 
        "lastchanged_date": "January 28, 2014", 
        "location": {
            "contact": {
                "email": "av.afanasyev@icloud.com", 
                "last_name": "\u0410\u043b\u0435\u043a\u0441\u0430\u043d\u0434\u0440 \u0410\u0444\u0430\u043d\u0430\u0441\u044c\u0435\u0432", 
                "phone": "89137544245"
            }, 
            "contact_backup": {
                "email": "bwcsmile@gmail.com", 
                "last_name": "Alexander Afanasyev"
            }, 
            "facility": {
                "address": {
                    "city": "Novosibirsk", 
                    "country": "Russian Federation", 
                    "zip": "630055"
                }, 
                "name": "Novosibirsk State Research Institute of Circulation Pathology"
            }, 
            "investigator": {
                "last_name": "Alexander V Afanasyev", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Russian Federation"
        }, 
        "number_of_arms": "2", 
        "official_title": "Left Atrium Reduction Versus no Left Atrium Reduction for Patients With Enlarged Left Atria and Persistent or Long Standing Persistent Atrial Fibrillation Undergoing Mitral Valve Surgery", 
        "overall_official": {
            "affiliation": "Meshalkin Research Institute of Pathology of Circulation", 
            "last_name": "Alexander V Bogachev-Prokophiev, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Russia: Ministry of Health of the Russian Federation", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Freedom from atrial fibrillation", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02047279"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Meshalkin Research Institute of Pathology of Circulation", 
            "investigator_full_name": "Alexander Bogachev-Prokophiev", 
            "investigator_title": "PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Rate of significant adverse events", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "source": "Meshalkin Research Institute of Pathology of Circulation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Meshalkin Research Institute of Pathology of Circulation", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}